BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17683712)

  • 1. [Probable levetiracetam-induced psychosis].
    Roig J; Carreño MM; Parellada E
    Med Clin (Barc); 2007 Jul; 129(7):278. PubMed ID: 17683712
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute psychosis associated with levetiracetam.
    Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
    Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probable psychosis associated with levetiracetam: a case report.
    Aggarwal A; Sharma DD; Sharma RC; Kumar R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):274-5. PubMed ID: 20854866
    [No Abstract]   [Full Text] [Related]  

  • 4. Levetiracetam-induced psychosis in a pregnant woman with prior substance abuse.
    Bui M; Baslet G; Weisholtz D; McElrath T
    Harv Rev Psychiatry; 2014; 22(3):193-200. PubMed ID: 24802726
    [No Abstract]   [Full Text] [Related]  

  • 5. Levetiracetam and psychosis.
    Rodríguez-Toledo S; Trebbau-López H; Reyes-Molón L; del Río-Vega J
    Actas Esp Psiquiatr; 2012; 40(1):49. PubMed ID: 22344497
    [No Abstract]   [Full Text] [Related]  

  • 6. Levetiracetam-induced acute psychosis in a child.
    Zaki SA; Gupta S
    Indian J Pharmacol; 2014; 46(3):341-2. PubMed ID: 24987186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam psychosis in children with epilepsy.
    Kossoff EH; Bergey GK; Freeman JM; Vining EP
    Epilepsia; 2001 Dec; 42(12):1611-3. PubMed ID: 11879376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Drug-induced psychosis with levetiracetam.
    Mula M; Trimble MR
    Can J Psychiatry; 2005 Dec; 50(14):948; author reply 948. PubMed ID: 16494265
    [No Abstract]   [Full Text] [Related]  

  • 9. Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures.
    Kumar N; Swaroop HS; Chakraborty A; Chandran S
    Indian J Pharmacol; 2014; 46(5):560-1. PubMed ID: 25298593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric adverse events during levetiracetam therapy.
    Mula M; Trimble MR; Yuen A; Liu RS; Sander JW
    Neurology; 2003 Sep; 61(5):704-6. PubMed ID: 12963770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of levetiracetam.
    Sirsi D; Safdieh JE
    Expert Opin Drug Saf; 2007 May; 6(3):241-50. PubMed ID: 17480174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
    Shukla G; Gupta A; Agarwal P; Poornima S
    Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced psychosis after long-term treatment with levetiracetam.
    Bayerlein K; Frieling H; Beyer B; Kornhuber J; Bleich S
    Can J Psychiatry; 2004 Dec; 49(12):868. PubMed ID: 15679219
    [No Abstract]   [Full Text] [Related]  

  • 14. A new antiepileptic drug.
    Shorvon SD; van Rijckevorsel K
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):426-9. PubMed ID: 11909894
    [No Abstract]   [Full Text] [Related]  

  • 15. Levetiracetam-induced thrombocytopenia.
    Kimland E; Höjeberg B; von Euler M
    Epilepsia; 2004 Jul; 45(7):877-8. PubMed ID: 15230717
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug points: Weight loss associated with levetiracetam.
    Hadjikoutis S; Pickersgill TP; Smith PE
    BMJ; 2003 Oct; 327(7420):905. PubMed ID: 14563748
    [No Abstract]   [Full Text] [Related]  

  • 17. Can High-Dose Levetiracetam Be Safe? A Case Report of Prolonged Accidental High-Dose Levetiracetam Administration and Review of the Literature.
    Kartal A
    Clin Neuropharmacol; 2017; 40(5):217-218. PubMed ID: 28682928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis following initiation of zonisamide.
    Michael CT; Starr JL
    Am J Psychiatry; 2007 Apr; 164(4):682. PubMed ID: 17403989
    [No Abstract]   [Full Text] [Related]  

  • 19. QT interval prolongation in a patient with LQT2 on levetiracetam.
    Issa NP; Fisher WG; Narayanan JT
    Seizure; 2015 Jul; 29():134-6. PubMed ID: 26076856
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics and indications of levetiracetam].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S110-6. PubMed ID: 12373663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.